Apo-Sitagliptin/Metformin XR 50 mg

APO-SITAGLIPTIN/METFORMIN XR 50 MG is an extended-release tablet combining sitagliptin and metformin for managing type 2 diabetes. This medication supports blood sugar control as part of a broader treatment plan.

APO-SITAGLIPTIN/METFORMIN XR 50 MG is commonly used to help manage type 2 diabetes by improving blood sugar levels. Sitagliptin works by increasing insulin production, while metformin reduces sugar production in the liver. This combination is often prescribed for individuals who require additional glycemic control beyond diet and exercise alone.

Common effects of APO-SITAGLIPTIN/METFORMIN XR 50 MG may include gastrointestinal discomfort, such as nausea or diarrhea, particularly when first starting the medication. Some users may also experience headaches or dizziness. These effects typically diminish as the body adjusts to the medication.

APO-SITAGLIPTIN/METFORMIN XR 50 MG should be taken as directed by a healthcare provider. It is important to follow the prescribed dosage and administration instructions. This medication should be stored at room temperature, away from moisture and heat. Always inform your healthcare provider about any other medications you are taking.

APO-SITAGLIPTIN/METFORMIN XR 50 MG may interact with certain medications, including those that affect kidney function or blood sugar levels. Alcohol consumption should be avoided as it can increase the risk of lactic acidosis, a serious side effect of metformin. Always consult a healthcare provider before starting or stopping any medication.